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A novel, simple, and reproducible method for cultivating pathological tissues obtained from human eyes during surgery was
developedusing viscoelasticmaterial as a tissue adherent to facilitate cell attachment and expansion and calcium imaging of cultured
cells challenged by mechanical and acetylcholine (ACh) stimulation as well as inflammatory studies. Anterior lens capsule-lens
epithelial cells (aLC-LECs) from cataract surgery and proliferative diabetic retinopathy (PDR) fibrovascular epiretinal membranes
(fvERMs) fromhuman eyeswere used in the study.Wehereby show calcium signaling in aLC-LECs bymechanical and acetylcholine
(ACh) stimulation and indicate presence of ACh receptors in these cells. Furthermore, an ex vivo study model was established for
measuring the inflammatory response in fvERMs and aLC-LECs upon TNF𝛼 treatment.
1. Introduction
Human eye diseasemodeling requires well established ex vivo
cell cultures. Such cultures allow studying diseases of interest
at a cellular level using multiple techniques. In addition, they
provide possibility to grow primary human eye cells with the
purpose of repairing a defect and eventually transplanting
them back to the patient in an autologous or heterologous
manner.
An important condition for growing ex vivo eye explant
cultures is to have an adherent environment. We developed a
simple method for attaching eye tissue explants to the surface
of a Petri dish by using surgical grade viscoelastic material,
otherwise routinely used in ophthalmic surgery [1].
Human anterior lens capsule-lens epithelial cells (aLC-
LECs) from cataract surgery and fibrovascular epiretinal
membranes (fvERM) from proliferative diabetic retinopathy
(PDR) were cultured adherently under viscoelastic material.
The single-layered LECs underlying the aLC aremetabolically
the most active part of the lens and are responsible for
sustaining physiological health of the tissue. ERMs are a
collection of cells and extracellular matrix that occur in
the inner, vitreal surface of the central retina. They have
contractile properties and can lead to visual disturbance
and metamorphopsia (distorted vision) due to their effect
on the underlying retina. FvERMs represent the final and
devastating stage of PDR and form, due to heavy hypoxia,
retinal ischemia and unbalanced glucose metabolism, the
result of which is a state of chronic inflammation [2, 3].
Cells growing out of cultured aLCs and fvERM explants
were studied functionally by examining intracellular calcium
[Ca2+]i signaling under adherent culture conditions. Calcium
signaling plays an important role in the regulation of cell
function, affecting every aspect of the cells’ life and death [4].
We hereby show free [Ca2+]i changes upon mechanical and
acetylcholine (ACh) stimulation in cultured cells obtained
from human aLCs under adherent conditions and indicate
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presence of ACh receptors in these cells. In addition, the
inflammatory nature of fvERMs and aLC-LECs as well as
their relation to tumor necrosis factor alpha (TNF𝛼) and
angiogenesis is addressed here.
2. Methods
2.1. Tissue Collection and Processing. All tissue collection
complied with the guidelines of the Helsinki Declaration and
was approved by the National Medical Ethics Committee
of Slovenia; all patients signed an informed consent form
before surgery which was performed at the Eye Hospital,
University Medical Centre (UMC), Ljubljana, Slovenia. Alto-
gether 11 patientswere included in this study—6 cultureswere
analyzed for mechanical stimulation and 5 cultures for ACh
stimulation,with the patients’ age ranging from70 to 92 years.
The aLC explants consisted of a monolayer of LECs
attached to the basal lamina andwere obtained fromunevent-
ful cataract surgeries due to progredient cataract. Lenses were
dissected so that the aLCs (i.e., basal lamina and associated
LECs) were isolated from the fiber cells that form the bulk
of the lens. FvERMs were obtained from patients undergoing
vitrectomy due to intravitreal hemorrhage in PDR.
All explants were obtained from single patients and were
usually placed in a single dish accordingly. Immediately after
isolation, the excised human eye explants were placed in
sterile tubes filled with DMEM:F12 (D8437, Sigma-Aldrich,
Ayrshire, UK), supplemented with 10% fetal calf serum (FCS)
(PAA Laboratories GmbH, Pasching, Austria), and trans-
ported from the operating room to the research department
in the same building. The explants were then transferred to
empty cell culture glass bottom Petri dishes (Mattek Corp.,
Ashland, MA, USA; 3.5 cm in diameter) or tissue culture 12-
well plates (TPP, Sigma, Germany) by using microdissecting
tweezers (WPI by Dumont, Med.Biologie, Germany). The
aLC explants were placed into the culture dish so that the
concave side with the LECs was on the top and oriented
upwards. The time of culturing ranged from 6 to 48 days.
2.2. Tissue Fixation/Adherence by Viscoelastic Material. For
obtaining adherent conditions, careful removal of the
remaining medium from the tissue cultures was performed
by a micropipette, and then viscoelastic (HEALON OVD,
AbbottMedical Optics, USA)was added on top of the explant
to allow for flattening or “ironing” of the tissue onto the
surface of the Petri dish (Figure 1).
For ex vivo cultivation under adherent conditions,
DMEM:F12 supplemented with 10% FCS was then added
slowly with the micropipette not to disturb or remove the
viscoelastic cover on top of the explants. The micropipette
tip was positioned close to the culture dish surface but far
away from the explant, so that the medium arrived softly in
contact with the viscoelastic and did not move the explant
from its location. The culture dishes were then kept in a CO
2
incubator (Innova CO-48; New Brunswick Scientific, Edison,
NJ, USA) at 37∘C and 5% CO
2
.
The culture dish was kept in the incubator without
moving for 2-3 days in order to allow the cells to attach and
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Figure 1: Method for adherent ex vivo cultivation of human eye
tissue explants in a cell culture Petri dish.
start proliferating out of the explant. Duringmedium change,
the medium was removed gently and a fresh one was added
subsequently by a micropipette from the opposite side of the
explant in the dish, the pipette tip being close to the surface
of the dish all the time. The viscoelastic dissolved over time
and got replaced by newmedium—time by which the explant
was fully attached to the surface of the culture dish.
2.3. Light Microscopy and Calcium Imaging. The prolifera-
tion and migration of the cells were recorded throughout
their continued growth using inverted light microscope
(Axiovert S100, Carl Zeiss, AG, Oberkochen, Germany).
The same microscope was used for [Ca2+]i measurements.
Image acquisition was carried out by a 12-bit cooled CCD
camera SensiCam (PCO Imaging AG, Kelheim, Germany).
The software used for the acquisition was WinFluor (written
by J. Dempster, University of Strathclyde, Glasgow, UK).
Microscope objectives used were 4x/0.10 Achroplan, 10x/0.30
Plan-Neofluar, 40x/0.50 LD A-plan, and 63x/1.25 oil Plan-
Neofluar (Zeiss).
The excitation filters usedweremounted on a Lambda LS-
10 filter wheel (Sutter Instruments Co., CA, USA) and had a
wavelength of 360 and 380 nm (Chroma Technology Corp.,
Bellows Falls, VT, USA). Excitation with the 360 nm filter
(close to the Fura-2 isosbestic point) allowed observation of
the cells’ morphology and of the changes in the concentration
of the dye, irrespective of the changes in [Ca2+]i, while the
360/380 nm ratio allowed visualization of the [Ca2+]i changes
in the cytoplasm. Image acquisition, timing, and filter wheel
operation were all controlled by WinFluor software via a
PCI6229 interface card (National Instruments, Austin, TX,
USA). The light source used was XBO-75W (Zeiss) Xe arc
lamp. The light intensity was attenuated when necessary
with grey filters with optical densities 0.5, 1, and 2 (Chroma
Technology Corp., Bellows Falls, VT, USA). The criteria for
selecting the region for imagingwere the presence of adherent
cells and good cell morphology both assessed by observation
of transilluminated and 360 nm fluorescence images. Indi-
vidual image frames were acquired every 500ms resulting in
frame cycles being 1 second long (two wavelengths).
For [Ca2+]i monitoring, the cell cultures were loaded
with the acetoxymethyl (AM) ester of Fura-2 (Fura-2 AM,
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Figure 2: Examples of attached human eye explants with the growing cells: (a) anterior lens capsule (aLC) in a 12-well plate; (b) fibrovascular
epiretinal membrane (fvERM) cells growing attached to and independently from the tissue explant in a cell culture Petri dish.
Invitrogen-Molecular Probes, Carlsbad, CA, USA), intracel-
lular calcium indicator. For loading, Fura-2 AM in dimethyl
sulfoxide (DMSO) was suspended in 3mL of medium (high
glucose medium with FBS) or physiological saline with (in
mM) NaCl (131.8), KCl (5), MgCl2 (2), NaH2PO4 (0.5),
NaHCO3 (2), CaCl2 (1.8), HEPES (10), glucose (10), pH
7.24 to the final working concentration of 2𝜇M (aLC). The
loading was done in the incubator at 37∘C for 30min (aLC).
After loading, the cell cultures were washed twice for 7min
with the medium or physiological saline. The final working
concentration of Fura-2 and the time of incubation/washing
were larger for larger eye explants (it depended on the explant
size).
Fura-2 dye has two excitation (absorption) peaks (340
and 380 nm), an isosbestic point at 360 nm and one emission
peak at 510 nm. Its absorption and fluorescent properties
change in accordance with Ca2+ binding (low [Ca2+]i—
high absorption at 380 nm, high [Ca2+]i—high absorption
at 340 nm while the absorption is not Ca2+ dependent at
the isosbestic point of 360 nm). The absorptive properties of
Fura-2 allow the use of ratio imaging (360/380 ratio), which
considerably reduces the effects of uneven dye loading, leak-
age of the dye, and photobleaching as well as problems asso-
ciated with measuring [Ca2+]i in cells of unequal thickness.
2.4. Mechanical and Acetylcholine (ACh) Stimulation. To test
responses to mechanical stimuli, a tip of a glass micropipette
mounted on a MP-285 micromanipulator (Sutter, Novato,
CA, USA) was used. Prior to use, the tip of the pipette was
heat-polished until it rounded up.
The agonist acetylcholine (ACh; Sigma, USA)was applied
in 10 𝜇M concentration, which was enough to induce >90%
maximal [Ca2+]i response, according to the data by Collison
et al. [12]. The agonist application as well as its washout from
the bath was driven simply by the hydrostatic pressure of a
35 cm of water column and controlled manually by a luer-
lock stopcock (WPI) and applied through a polyethylene
plastic tubing (inner diameter 2mm), attached to the coarse
micromanipulator. The excess bathing solution was removed
by a suction line.
2.5. Secretion of Inflammatory Cytokines by ELISA. The
expanded fvERM cells were plated onto 6-well plates at
a density of 2 × 105 cells per well in triplicates. Similar
plating was carried out in case of the aLC-LECs until proper
cell number was achieved for cytokine measurements. After
24 hrs, the medium was changed, and the cells were treated
with 100 ng/mL recombinant human TNF𝛼 (Preprotech,
Rocky Hill, NJ, USA) for additional 24 hours. The secreted
cytokines, IL-6, and IL-8 were analyzed by commercial
ELISA kit (R&D, Germany) according to the manufacturer’s
protocol.Three independent experiments were performed on
three different outgrowing cells from both fvERM and aLC.
3. Results
3.1. HumanEye Explant Tissues Adhere to the Cell CultureDish
under a Gravitational Force of Viscoelastic Material. Novel,
simple, and reproducible method for ex vivo cultivation of
human explant tissues (aLCs and fvERMs) was established
using viscoelastic material (Figure 1).
The cells started proliferating out of the explants in 2-3
days (Figure 2).Themethod for attachment of human eye tis-
sue explants to the 12-well plates is shown in Figure 2(a)—the
aLC explant and the cells are flattened under the gravitational
force of the viscoelastic material. The fvERM cells grew out
of the explants within 24 hours and continued proliferating
independently throughout the study period (for more than 6
months) (Figure 2(b)).
3.2. Mechanical Stimulation and ACh Induce Rise in [𝐶𝑎2+]
𝑖
in
the aLC-LECs. The functionality of the aLC-LECs attached
under the viscoelastic was examined during mechanical
stimulation and application of agonist ACh, both of which
induced rise in the [Ca2+]i. Representative examples of 6
explant cultures were analyzed for mechanical stimulation
containing 27 cells being stimulated (mostly the cells on the
glass surface and some on the aLC); similarly, representative
examples of 5 explant cultures were analyzed for ACh stim-
ulation. Figure 3 shows the calcium signaling upon agonist
ACh stimulation of the aLC explant-cultured cells. The oscil-
lations of [Ca2+]i are clearly visible here, with each cell having
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Figure 3: Calcium signaling upon agonist ACh stimulation of the aLC explant-cultured cells (a). The traces (b) represent the time courses
of the 360/380 ratio (𝑅), proportional to [Ca2+]i and correspond to the regions of interest (ROI) shown on the B&W image (a) in the same
colors (explant growth time: 28 days).
its own frequency of oscillation (Figure 3(b), upper part): 50
cells were analyzed here, out of which 15 (30%) had oscillating
response with average of 16.6 ± 4.4 sec from minimum to
minimum. Accommodation can be observed for the green
trace as the interval between the two maxima decreases with
time, while a time delay of 2-3 sec in the [Ca2+]i propagation
can be seen (Figure 3(b), lower part) needed for the [Ca2+]i
to reach its first maximum for different ROIs of the same cell
(blue and red). No mechanically stimulated cell responded
at oscillation manner. The transient responses to mechanical
stimulation were usually comparable to those elicited by
ACh.
The calcium signaling upon mechanical stimulation of a
single cell of the aLC explant culture showed [Ca2+]i propaga-
tion as well (Figure 4)—in the example shown, 2/6 cells had
response with two peaks, the first one being bigger than the
other and the time interval between the peak maxima being
25 and 26 sec; the rest of the cells had no or very small calcium
increase.The blue ROI represents the stimulation site and the
red ROI represents the more distal site. There is a delay of
around 5 sec in the time needed for the [Ca2+]i to reach its
maximum at two selected ROIs. The increases in [Ca2+]i in
the cells surrounding themechanically stimulated cell suggest
the involvement of intercellular connections.
The intercellular dendrite connection strength upon
mechanical fluid movement for the nonattached dendrites
in aLC explant culture could also be observed (Figure 5).
Indeed, a confirmation that the [Ca2+]i changes are not
dependent on themechanical effect of fluidmovement but on
ACh is shown by the fact that [Ca2+]i increase occurs much
later (𝑡 = 101 s) in comparison to the dendritic movement
dependent on the mechanical effect of fluid movement (𝑡 =
39–47 s) as visible on Figure 5(c).
The [Ca2+]i dynamics upon mechanical stimulation of
fvERMs has been previously described by our group [5],
which is a proof of the viability and functionality of these cells.
3.3. Measurement of Proinflammatory/Angiogenic Factors
Secreted by the fvERM Outgrowing Cells upon TNF𝛼 Treat-
ment. The outgrowing cells from the fvERMs showed basal
expression of the proinflammatory cytokine interleukin-
(IL-) 6 ex vivo, which was further enhanced by TNF𝛼
stimulation. Similar enhancement was noted in the proin-
flammatory cytokine release of IL-8 upon TNF𝛼 stimulation
(Figure 6(a)). In the case of aLC-LECs, there were no basal
IL-6 and IL-8 responses and TNF𝛼-induced IL-8 secretion
(Figure 6(b)).
4. Discussion
Anovel, simple, and reproduciblemethod for creating adher-
ent conditions for human eye explants and ex vivo cellular
expansion using viscoelastic material as well as studies on
calcium dynamics and inflammation is established here. The
outgrowing cells, over time, migrate out of the explants and
grow adherently onto the surface of the cell culture dish,
showing signs of continuous proliferation.
Alternative adherence methods for tissues explants can
be the use of dry surface, concentrated serum drop, or
the fibrin-glue method—the latter being used mostly for
in vivo purposes. The advantage of the viscoelastic method
is in avoiding extreme conditions such as dryness and
serum stimulants, yet preserving natural architecture of the
tissue and standard nutritional conditions for the cells. The
viscoelastic is an inert substance having viscous, elastic,
and gravitational properties which force the graft to attach
to a surface. The viscoelastic HEALON OVD is used in
ophthalmic surgical procedures to maintain deep anterior
chamber, which facilitates manipulation inside the eye with
reduced trauma to the corneal endothelium and other ocular
tissues.
Two tissue types are used here to establish adherent ex
vivo explant cultures: aLCs containing LECs and fvERMs.
Tissue and cell adherence allow measurement of the [Ca2+]i
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Figure 4: Calcium signaling upon mechanical stimulation of a single cell of the aLC explant culture, showing the [Ca2+]i propagation and
involvement of intercellular connections. The traces (b) represent the time courses of the 360/380 ratio (𝑅), proportional to [Ca2+]i and
correspond to the regions of interest (ROI) shown in the B&W image (a) in the same colors. (c) A series of the 360/380 ratio images at the
time points are indicated. The values for 𝑅 are color coded with blue/green representing low ratio values and yellow/red representing high
ratios (explant growth time: 14 days).
upon mechanical or pharmacological stimulation, giving
advantage of having less noise from cellularmovementwithin
the cell culture dish.
Precise regulation of the [Ca2+]i levels is critical formain-
taining normal cellular function, fluctuations ofwhich can act
as signals for numerous physiological or pathological events.
Imbalance in the [Ca2+]i levels may lead to development of
cataract in the lens [6–9]. Our results indicate an increase in
the [Ca2+]i upon mechanical stimulation and application of
ACh to aLC-LECs. Previously, mechanical stimulation had
been used to induce [Ca2+]i rise in cultured bovine LECs [10].
Such stimulation of a single cell within a confluent layer was
shown to initiate cell-to-cell calcium signaling. Contractions
in human aLECs attached to the surgically isolated capsules
could also be mechanically induced [11].
The increase in [Ca2+]i suggests involvement of inter-
cellular connections between the LECs studied ex vivo. In
human aLECs, ACh binds to M1 muscarinic receptors (M1
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Figure 5: The intercellular dendrite connection strength upon mechanical fluid movement for the nonattached dendrites in aLC explant
cultures. The traces (b) represent the time courses of the 360/380 ratio (𝑅), proportional to [Ca2+]i and correspond to the regions of interest
(ROI) shown in the B&W image(a) in the same colors. (c) A series of the 360/380 ratio images at the time points are indicated.The values for
𝑅 are color coded with blue/green representing low ratio values and yellow/red representing high ratios (explant growth time: 21 days).
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Figure 6: Cytokine secretion by aLC-LEC and fvERM outgrowing cells upon TNF𝛼 treatment.
mAChR) and induces a rise in [Ca2+]i [12–14]. The origin
of ACh in the lens is not clear; however, its presence can
certainly affect cells of the immune system, which possess
membrane bound mAChR and nicotinic (nAChR) receptors
that can regulate their function [15–18]. Choline acetyltrans-
ferase (ChAT) enzyme expression in CD4+ and CD8+ T-
cells has been previously shown, suggesting that lymphocytes
possess all of the necessary biochemical machinery to pro-
duce this neurotransmitter, thereby regulating their function
in an autocrine manner [19]. In general, according to the
data obtained in mammalian models, it has been proposed
that cholinergic activity increases as a result of direct contact
between T-cell receptor (TCR)/CD3 molecules, CD4 and
CD8 coreceptors, and other accessory molecules [17]. Exper-
imental data obtained by means of in vitro models and in
absence of neuronal innervation have shown ChAT produc-
tion in B-cells, macrophages, and dendritic cells from mice;
production of this enzyme appears to be upregulated by Toll-
like receptor (TLR) activation, a pathway acting via MyD-88
[19].Moreover,Neumann et al. in 2007 [20] showed in human
leukocytes that antagonists of the nicotinic and muscarinic
receptors (tubocurarine and atropine, resp.) could signif-
icantly decrease the phagocytic functions of granulocytes
but did not change the migration of these cells, whereas in
Jurkat cells (the human helper T-lymphocyte leukemic line)
exposure to oxotremorine-M (Oxo-M), a cholinergic agonist,
could significantly increase the synthesis of IL-2, which could
be related to the transcriptional factor activator protein-
1 (AP-1) and mitogen-activated protein kinases (MAPK)
[21]. Experiments with MOLT-3 cells (the human T-cell
leukemia line) showed involvement of the protein kinase
C (PKC) signaling pathway-MAPK, cyclic adenosine 3󸀠,5󸀠-
monophosphate (cAMP), and calcineurin in the synthesis of
ACh [18]. There are findings suggesting that photoreceptor
outer segments (OS) communicate via neurotransmitters
such as ACh and SLURP-1, while RPE cells may receive
these signals through nAChRs𝛼7 in their microvilli [22].
It cannot be ruled out, however, that other cells including
LECs can be activated by ACh in such a manner. Indeed,
evidence that RPE cells can express nAChRs, similar to how
other epithelial cells do, has been related to cell development,
death, migration, and angiogenesis [23]. The nAChR𝛼7 is
responsible for the inhibition of macrophage TNF release via
the parasympathetic anti-inflammatory pathway [24], thus
opening up new avenues for the design of experimental anti-
inflammatory therapeutics in different segments of the eye.
The adherent aLC-LEC cultures can be used for inflam-
matory studies as well. Inhibition of aldose reductase (AR),
for example, can prevent lipopolysaccharide- (LPS-) induced
inflammatory response in human LECs [25], such as syn-
thesis of large quantities of bioactive inflammatory medi-
ators: nitric oxide, prostaglandins, TNF-𝛼, IL-1, IL-6, and
IFN-𝛾 [26–28]. Ocular tissues can be exposed to various
proinflammatory factors released due to injury, infection, or
disease [29–31]. The lens can also be exposed to such factors
appearing in the aqueous humor during bacterial infections
[32–34]. It was shown that incubation of human LECs with
cytokines such as TNF𝛼 increases the activation of nuclear
factor kappa-light-chain-enhancer of activated B-cells (NF-
𝜅B) and causes cytotoxicity [35, 36] as well as apoptosis in
human LECs (HLECs). Preventing NF-𝜅B activation by AR
inhibitors should therefore rescueHLECs from cell death and
inflammation [36, 37]. Transforming growth factor- (TGF-)
𝛼 and TGF-𝛽 (2), mRNA can also be synthesized by human
cataract LECs in situ, while IL-8 mRNA can be synthesized in
vitro [38]. IL-1, IL-6, and basic fibroblast growth factor (b-
FGF) can be produced in vivo by residual LECs following
cataract surgery, which can cause postoperative inflammation
and LEC proliferation. IL-1 and TGF𝛽may participate in the
postoperative inflammation by increasing PGE2 synthesis by
residual LECs [39]. The role of these cytokines which can be
synthesized by the LECs in vitromay, therefore, be significant
in studying proliferation of LECs after cataract surgery, which
can eventually lead to inflammation and secondary cataract
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[40]. It was revealed that the expression of TNF𝛼 gene in
LECs is more extended compared to that of IL-1𝛼 in lens
capsule samples obtained from cataract surgery [35].
Cell death studies using terminal deoxynucleotidyl
transferase- (TdT-) mediated dUTP nick-end labeling
(TUNEL) of LECs in capsulotomy specimens found necrotic
cell death caused by damage during or soon after cataract
surgery. Loss of cells from the lens epithelium by apoptosis
or other mechanisms of cell death does not seem to play a
major role in age-related cataract formation [41].
Proper phenotypization of the cell surface markers of
ex vivo cultured cells growing out of human fvERMs from
PDR gives possibility to study their role and function in
immunity. The cell adhesion molecules (CAMs) and inte-
grins profile are meaningful in structuring the cell-based
tissue integrity and immune processes. Application of high-
throughput screening by angiogenic protein arrays allows
measuring the angiogenic potential of fvERM outgrowing
cells under presence or absence of proinflammatory factor
TNF𝛼 [5].
Presence of TNF𝛼 in the vitreous is important marker
for PDR [42, 43]. High levels of IL-6, IL-8, and TNF𝛼
have been measured in the vitreous of PDR patients [2, 3],
giving support to the role of inflammatory cytokines in
angiogenesis in PDR. Increased secretion of IL-6 and IL-
8 was also measured in our fvERM outgrowing cells upon
TNF𝛼 stimulation using the ELISA method. Understanding
their role can provide important diagnostic and therapeutic
targets for the treatment and prevention of inflammation and
angiogenesis in PDR.
Fourteen main TNF𝛼-inducible proteins have been
reported in the literature in relation to immune response,
among them being the pentraxin-related protein 3 (PTX3),
a known marker for rapid primary local activation of innate
immunity and inflammation. ICAM-1 expression increased
upon TNF𝛼 proinflammatory stimulus in primary hRPE
cells, similar to the fvERM outgrowing cells, giving a link to
the functionwhich these activated cells may play in leukocyte
adhesion [44–50]. Endothelin 1 (ET-1) molecule secreted
by endothelial cells when stimulated by proinflammatory
cytokines increases in the vitreous of patients with PDR
[51], also detected in the fvERMs upon TNF𝛼 treatment
in our previous study [5]. IL-1𝛽 concentrations are higher
in the vitreous of patients with PDR compared to non-
PDR and controls, indicating that there could be a mini-
mal acute inflammatory activity present in the early stages
of retinopathy, which progressively increases in the most
advanced stages of the disease. In comparison, the level of
IL-1Ra, which is an anti-inflammatory cytokine, was found
to be significantly higher in the controls compared to those
of PDR [51]. The process of complement C5a activation leads
to release of cytokines, reactive oxygen species, proteolytic
enzymes, and other proinflammatory molecules [52].
Recently, the extracellular high-mobility group box-1
(HMGB1) was reported as proinflammatory cytokine [53–56]
playing a role in angiogenesis [53, 57–59], and it was detected
in the vitreous of patients with PDR together with MCP-
1 and sICAM-1 [60]. HMGB1 and the soluble receptor for
advanced glycation-end products (RAGE) are also expressed
by vascular endothelial and stromal cells in fvERM from
PDR, suggesting a role for the HMGB1/RAGE signaling axis
in the progression of PDR [53, 57–59]. A significantly elevated
level of five novel cytokines including sCD40L, GM-CSF,
IFN𝛼2, IL-12p40, and MCP-3 in the vitreous of PDR patients
previously not associated with the disease was also recently
reported [61].
In conclusion, providing adherent, inert conditions for ex
vivo cultivation and expansion of cells from different tissues
is crucial for establishing disease models. Using viscoelastic
material as a novel and simple method for achieving tissue
and cell adherence can empower studies on intracellular
calcium dynamics upon mechanical stimulation, calcium
signaling, and intercellular communication upon ACh stim-
ulation as well as inflammatory studies in as little background
noise and artifacts as possible, void of detachment-associated
cell death and associated inflammation. Future studies on
cell functionality and homeostasis using calcium imaging and
inflammation screening widen the possibilities for develop-
ment of pharmacological and cell-based therapies that are
attractive approach for treating eye diseases.
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